1. Home
  2. AENT vs TLSI Comparison

AENT vs TLSI Comparison

Compare AENT & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alliance Entertainment Holding Corporation

AENT

Alliance Entertainment Holding Corporation

N/A

Current Price

$6.46

Market Cap

286.5M

ML Signal

N/A

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

N/A

Current Price

$4.67

Market Cap

270.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AENT
TLSI
Founded
1990
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Durable Goods
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
286.5M
270.2M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
AENT
TLSI
Price
$6.46
$4.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$10.00
$7.00
AVG Volume (30 Days)
16.8K
107.2K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
233.33
N/A
EPS
0.32
N/A
Revenue
$2,700,000.00
$45,151,000.00
Revenue This Year
$3.44
$35.45
Revenue Next Year
$1.64
$37.58
P/E Ratio
$16.56
N/A
Revenue Growth
N/A
53.41
52 Week Low
$4.36
$2.20
52 Week High
$8.80
$7.95

Technical Indicators

Market Signals
Indicator
AENT
TLSI
Relative Strength Index (RSI) 56.72 42.35
Support Level $5.18 $4.21
Resistance Level $6.25 $4.82
Average True Range (ATR) 0.31 0.29
MACD 0.03 -0.08
Stochastic Oscillator 97.20 4.23

Price Performance

Historical Comparison
AENT
TLSI

About AENT Alliance Entertainment Holding Corporation

Alliance Entertainment Holding Corp is a distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world. The company has two divisions: Alliance Home Entertainment, which offers full-service support across production, marketing, and retail execution. and Alliance Authentic, which focuses on licensed collectibles and branded merchandise, including partnerships with Handmade by Robots, Master Replicas, and Weta Workshop.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

Share on Social Networks: